Cytostatic evaluations of nucleoside analogs related to unnatural base pairs for a genetic expansion system

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 20, 2007, Pages 5582-5585

  Kimoto, Michiko ^a   Moriyama, Kei ^b   Yokoyama, Shigeyuki ^a,c,d   Hirao, Ichiro ^a,b  

^a RIKEN YOKOHAMA INSTITUTE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d RIKEN HARIMA INSTITUTE   (Japan)

Author keywords

Antitumor drug; Base analogs; Cytostatic activity; Nucleoside analogs; Unnatural base pairs

Indexed keywords

1 DEAZAPURINE NUCLEOSIDE; 2 AMINO 6 (2 THIENYL)PURINE; 2 AMINO NUCLEOSIDE; 2 PYRROLECARBOXALDEHYDE; 2' DEOXY NUCLEOSIDE; 7 (2 THIENYL)IMIDAZO[4,5 B]PYRIDINE; ALDEHYDE DERIVATIVE; NUCLEOSIDE; PURINE DERIVATIVE; PYRIDIN 2 ONE; PYRIDINE DERIVATIVE; RIBONUCLEOSIDE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; BASE PAIRING; CONTROLLED STUDY; CYTOSTASIS; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; FIBROBLAST; GENETICS; HUMAN; HUMAN CELL; HYDROGEN BOND;

ANTINEOPLASTIC AGENTS; BASE PAIRING; CELL LINE; CELL SURVIVAL; HUMANS; MOLECULAR STRUCTURE; NUCLEOSIDES;

EID: 34548581964     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2007.07.088     Document Type: Article

References (20)

1. Benner S.A., Burgstaller P., Battersby T.R., and Jurczyk S. In: Gesteland R.F., Cech T.R., and Atkins J.F. (Eds). The RNA World (1999), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York 163-181
2. Henry A.A., and Romesberg F.E. Curr. Opin. Chem. Biol. 7 (2003) 727
3. Hirao I. Curr. Opin. Chem. Biol. 10 (2006) 622
4. Fujiwara T., Kimoto M., Sugiyama H., Hirao I., and Yokoyama S. Bioorg. Med. Chem. Lett. 11 (2001) 2221
5. Hirao I., Ohtsuki T., Fujiwara T., Mitsui T., Yokogawa T., Okuni T., Nakayama H., Takio K., Yabuki T., Kigawa T., Kodama K., Yokogawa T., Nishikawa K., and Yokoyama S. Nat. Biotechnol. 20 (2002) 177
6. Hirao I., Kimoto M., Mitsui T., Fujiwara T., Kawai R., Sato A., Harada Y., and Yokoyama S. Nat. Methods 3 (2006) 729
7. Hocek M., Holý A., Votruba I., and Dvořáková H. J. Med. Chem. 43 (2000) 1817
8. Hocek M., Holý A., Votruba I., and Dvořáková H. Collect. Czech. Chem. Commun. 65 (2000) 1683
9. Hocek M., Holý A., Votruba I., and Dvořáková H. Collect. Czech. Chem. Commun. 66 (2001) 483
10. Hocek M., Holý A., and Dvořáková H. Collect. Czech. Chem. Commun. 67 (2002) 325
11. Hocek M., Nauš P., Pohl R., Votruba I., Furman P.A., Tharnish P.M., and Otto M.J. J. Med. Chem. 48 (2005) 5869
12. Hocek M., Šilhár P., Shih I., Mabery E., and Mackman R. Bioorg. Med. Chem. Lett. 16 (2006) 5290
13. Hirao I., Fujiwara T., Kimoto M., and Yokoyama S. Bioorg. Med. Chem. Lett. 14 (2004) 4887
14. Hirao I., Harada Y., Kimoto M., Mitsui T., Fujiwara T., and Yokoyama S. J. Am. Chem. Soc. 126 (2004) 13298
15. Ohtsuki T., Kimoto M., Ishikawa M., Mitsui T., Hirao I., and Yokoyama S. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 4992
16. 4 cells/ml for HT-1080 and WI-38) were plated into 96-well microplates and were incubated for 24 h (for CCRF-CEM) or 4 h (for HT-1080 and WI-38). Various concentrations of nucleoside solutions (10 μl) in PBS containing 5% DMSO were then added into each well. The presence of 5% DMSO, which was used to dissolve the nucleosides, did not affect the cell growth (data not shown). After an incubation for 72 h, the MTT solution (25 μl) in PBS (5 mg/ml) was added to each well, and the plates were incubated for an additional 2 h. Finally, a 100 μl aliquot of a lysis solution (50% DMF/20% SDS) was added to each well, in order to dissolve the resulting MTT-formazan, and after an incubation for 16 h, the absorbance of the formazan product obtained by MTT reduction was measured at 570 nm, using a microplate reader.
17. Matsuda A., Hattori H., Tanaka M., and Sakaki T. Bioorg. Med. Chem. Lett. 6 (1996) 1887
18. Hocek M., Štěpnička P., Ludvi{dotless}́k J., Ci{dotless}́sařová I., Votruba I., Řeha D., and Hobza P. Chem. Eur. J. 10 (2004) 2058
19. Hocek M., and Votruba I. Bioorg. Med. Chem. Lett. 12 (2002) 1055
20. Patel M., Agarwal R., and Ardalan B. J. Cancer Res. Clin. Oncol. 130 (2004) 453